Skip to main content
Apogee Therapeutics, Inc. logo

Apogee Therapeutics, Inc. — Investor Relations & Filings

Ticker · APGE ISIN · US03770N1019 US Manufacturing
Filings indexed 231 across all filing types
Latest filing 2026-04-24 Annual Report
Country US United States of America
Listing US APGE

About Apogee Therapeutics, Inc.

https://apogeetherapeutics.com/

Apogee Therapeutics, Inc. is a clinical-stage biotechnology company that develops differentiated biologics for immunological and inflammatory (I&I) diseases. The company's pipeline consists of novel antibody therapeutics targeting well-established biological pathways to treat conditions such as atopic dermatitis (AD), asthma, and chronic obstructive pulmonary disease (COPD), as well as other dermatological and respiratory disorders. Apogee's scientific approach focuses on creating therapies with the potential for improved efficacy and less frequent dosing, aiming to advance the standard of care for patients with these conditions.

Recent filings

Filing Released Lang Actions
ARS - Apogee Therapeutics, Inc. (0001974640) (Filer)
Annual Report
2026-04-24 English
4 - Apogee Therapeutics, Inc. (0001974640) (Issuer)
Director's Dealing
2026-03-28 English
SCHEDULE 13D/A - Apogee Therapeutics, Inc. (0001974640) (Subject)
Major Shareholding Notification
2026-03-27 English
8-K - Apogee Therapeutics, Inc. (0001974640) (Filer)
Regulatory Filings
2026-03-25 English
8-K - Apogee Therapeutics, Inc. (0001974640) (Filer)
Regulatory Filings
2026-03-23 English
4 - APOGEE THERAPEUTICS, INC. (0001974640) (Filer)
Director's Dealing
2026-03-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.